Reference
Dizon S, et al. Insights Into the Recognition and Management of SGLT2-Inhibitor-Associated Ketoacidosis: It's Not Just Euglycemic Diabetic Ketoacidosis. Canadian Journal of Diabetes 41: 499-503, No. 5, Oct 2017. Available from: URL: http://doi.org/10.1016/j.jcjd.2017.05.004 - Canada
Rights and permissions
About this article
Cite this article
Canagliflozin/dapagliflozin/prednisone. Reactions Weekly 1718, 54 (2018). https://doi.org/10.1007/s40278-018-51398-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-018-51398-7